Skip to main content
logo
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
38,900
-1,200 (-2.99%)
At close: Aug 24, 2026

HEM Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Market Capitalization
280,436327,494114,874
Market Cap Growth
111.48%185.09%-
Enterprise Value
287,684334,986-
Last Close Price
38900.0045850.0016500.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
PS Ratio
19.4625.237.62
PB Ratio
161.8162.804.40
P/TBV Ratio
-92.814.54

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
EV/Sales Ratio
19.9625.81-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Debt / Equity Ratio
11.213.690.30
Net Debt / Equity Ratio
4.021.05-0.13
Net Debt / EBITDA Ratio
-0.48-0.420.66
Net Debt / FCF Ratio
-0.39-0.300.28
Asset Turnover
0.320.29-
Inventory Turnover
12.829.97-
Quick Ratio
0.340.381.73
Current Ratio
0.480.561.91
Return on Equity (ROE)
-194.38%-151.43%-
Return on Assets (ROA)
-23.77%-21.96%-
Return on Capital Employed (ROCE)
-218.20%-137.30%-27.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Aug '26 Dec '25 Dec '24
Earnings Yield
-9.13%-7.28%-6.66%
FCF Yield
-6.34%-5.53%-10.77%
Buyback Yield / Dilution
-8.40%-10.68%-